Compare Pfizer Inc (PFE) vs Walmart Stores Inc (WMT) Price & Performance

Pfizer (PFE) trades at $24.75, down 1.2% on the day, with a neutral technical outlook. The company maintains strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $0.75 beating expectations of $0.722. Pfizer demonstrates robust profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated from pandemic peaks. Recent news highlights the company's focus on AI drug discovery and pipeline development.

Pfizer presents a value opportunity trading below analyst consensus target of $28.25, with 38% of analysts rating it Buy. The stock offers a solid dividend yield with recent $0.43 payments. Key risks include patent expirations and revenue normalization post-COVID, while catalysts include obesity and oncology pipeline developments in 2026.

Walmart (WMT) trades at $112.20, down 1.79% amid bearish technical signals despite strong fundamentals. The company has consistently beaten earnings estimates in recent quarters with Q2 2026 EPS expected at $0.74. Revenue growth remains robust at $681B for 2025, with net income margin improving to 3.13%. Technical indicators show bearish momentum with support at $109 and resistance at $114.

Walmart presents a compelling long-term investment with 73% analyst buy ratings and $142.33 consensus price target representing 27% upside. Risks include competitive pressure from Amazon, margin compression concerns, and economic sensitivity. The company's strong cash flow generation and dividend program provide shareholder value stability amid market volatility.